{
    "clinical_study": {
        "@rank": "114347", 
        "arm_group": [
            {
                "arm_group_label": "SurgiMend\u00ae PRS (ADM)", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects enrolled in to this cohort will receive SurgiMend\u00ae PRS (ADM) product during the first stage of the reconstruction (expander insertion)."
            }, 
            {
                "arm_group_label": "No ADM", 
                "arm_group_type": "No Intervention", 
                "description": "Subjects enrolled in to this cohort will not receive an acellular dermal matrix (ADM) product during the first stage of the reconstruction (expander insertion)."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective clinical study comparing two-stage breast reconstruction following\n      mastectomy with and without the use of SurgiMend\u00ae PRS  fetal bovine collagen matrix in\n      patients with pre-mastectomy radiation therapy."
        }, 
        "brief_title": "SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy", 
        "completion_date": {
            "#text": "September 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient is at least 18 years of age\n\n          -  Patient is female\n\n          -  Patient is undergoing immediate, two-stage breast reconstruction following mastectomy\n             with or without the use of SurgiMend\u00ae PRS\n\n          -  Patient has previously undergone pre-mastectomy XRT for breast cancer, with\n             lumpectomy or partial mastectomy, with the previously irradiated breast now being\n             reconstructed (with or without contralateral mastectomy & reconstruction)\n\n          -  Patient utilized a textured expander only\n\n          -  Patient utilized a smooth gel permanent implant only\n\n          -  Patient has agreed and is able to comply with the study follow-up requirements\n\n          -  Patient or guardian has provided consent for participation\n\n        Exclusion Criteria:\n\n          -  Patient is undergoing single-stage breast reconstruction\n\n          -  Patient is undergoing a delayed reconstruction\n\n          -  Patient is undergoing reconstruction using a smooth tissue expander, textured gel\n             breast implant or any saline breast implant.\n\n          -  Patient is undergoing planned reconstruction using autologous tissue\n\n          -  Patient has a known hypersensitivity to collagen or bovine derived materials\n\n          -  Patient is currently pregnant, nursing, or planning a pregnancy during the course of\n             the study\n\n          -  Patient who has had pre-mastectomy XRT bilaterally for breast cancer (either at the\n             same time or separated in time)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01959867", 
            "org_study_id": "TEI-BR-001"
        }, 
        "intervention": {
            "arm_group_label": "SurgiMend\u00ae PRS (ADM)", 
            "intervention_name": "SurgiMend\u00ae PRS", 
            "intervention_type": "Device", 
            "other_name": "ADM, acellular dermal matrix"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "mastectomy", 
            "breast reconstruction", 
            "bovine", 
            "ADM", 
            "breast cancer", 
            "breast implants", 
            "breast expanders", 
            "radiation therapy"
        ], 
        "lastchanged_date": "October 9, 2013", 
        "number_of_arms": "2", 
        "official_title": "Clinical Study Comparing Two-Stage Breast Reconstruction Following Mastectomy With and Without the Use of SurgiMend\u00ae PRS Fetal Bovine Collagen Matrix in Patients With Pre-Mastectomy Radiation Therapy", 
        "overall_contact": {
            "email": "awerner@teibio.com", 
            "last_name": "Andrea Werner", 
            "phone": "781-268-1616", 
            "phone_ext": "270"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Capsular Contracture Rate (Baker III/IV):  Reduction from control  through 12 months after expander-to-permanent implant exchange", 
                "measure": "Capsular Contracture Rate", 
                "safety_issue": "No", 
                "time_frame": "12 months Post-Exchange"
            }, 
            {
                "description": "No decrease in overall patient satisfaction from control as measured by the BREAST-Q Reconstruction Module Patient Satisfaction with Breasts survey, all questions a-p.\nIncrease in patient satisfaction from control as measured by the BREAST-Q Reconstruction Module Patient Satisfaction with Breasts survey, questions related to capsular contracture.", 
                "measure": "Breast Q", 
                "safety_issue": "No", 
                "time_frame": "12 months Post-Exchange"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01959867"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of capsule procedures performed", 
                "measure": "No. Capsule Procedures", 
                "safety_issue": "Yes", 
                "time_frame": "12 months Post-Exchange"
            }, 
            {
                "description": "Patient: (BREAST-Q Reconstruction Module) Surgeon: (panel review of standard photographs)", 
                "measure": "Cosmetic Assessment", 
                "safety_issue": "No", 
                "time_frame": "12 months Post-Exchange"
            }, 
            {
                "description": "Time to Completion (expand-to-implant exchange)", 
                "measure": "Time to Completion", 
                "safety_issue": "No", 
                "time_frame": "12 months Post-Exchange"
            }, 
            {
                "description": "Procedural Attributes: Total number of OR procedures", 
                "measure": "Total number of OR procedures", 
                "safety_issue": "No", 
                "time_frame": "12 month follow-up visit"
            }, 
            {
                "description": "Procedural Attributes: Total number of (\"in office\" and OR procedures)", 
                "measure": "Total number of visits", 
                "safety_issue": "No", 
                "time_frame": "12 month follow up visit"
            }
        ], 
        "source": "TEI Biosciences Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "TEI Biosciences Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}